Patients with hypercholesterolemia are at increased risk of infarction and stroke and require some care. Regarding food, it ...

Expert opinion from Shobha S Reddy MBBS, Masters in Diabetology, General Practitioner & Diabetologist · 15 years of ...

Discover Albireo Pharma Inc's groundbreaking patent for treating cardiovascular, metabolic, gastrointestinal, and liver diseases with innovative compounds. Learn how formula (I) derivatives offer a ...

According to the Cleveland Clinic, leg cramping can be one sign of high cholesterol. This means that the cholesterol has ...

Praluent Approved for Pediatric Patients With Heterozygous Familial Hypercholesterolemia Tryvio (aprocitentan) Endothelin receptor antagonist Treatment of hypertension in combination with other ...

Over a 20-year study, adherence to the Mediterranean diet significantly reduced the incidence of hypertension among adults ...

is indicated as adjunctive therapy to reduce low-density lipoprotein cholesterol (LDL-C): in adults with primary hyperlipidemia including heterozygous familial hypercholesterolemia (HeFH); in ...

CPAP benefited patients with OSA events averaging 19.5 seconds or less (HR, 0.46) and potentially harmed those with longer OSA events and hypercholesterolemia (HR, 2.24). In patients with obstructive ...

The novel agent has shown no immunogenicity issues thus far and might be a promising new PCSK9 inhibitor option.

Patients went home with self-testing devices plus remote access to a cardiologist—readmissions, events, and symptoms improved ...

Analysts' ratings for Regenxbio (NASDAQ:RGNX) over the last quarter vary from bullish to bearish, as provided by 9 analysts.

including heterozygous familial hypercholesterolemia. Both approvals eliminate the statin use requirement for Nexletol and Nexlizet, allowing patients to take either medication with or without a ...